{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "T",
          "alt": "A",
          "position": "21"
        },
        "variant_string_id": "PINK1 T21A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The study aimed to analyze fibroblasts from a patient carrying the homozygous mutation p.W437X in the PTEN-induced kinase 1 (PINK1), which manifested a very early onset parkinsonism.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines that the patient has a homozygous mutation in PINK1 gene, which is associated with an early onset Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper uses enzyme activity assay to analyze the effect of the variant on the protein function.",
          "judgment": "Yes",
          "reasoning": "Enzyme activity assays are a standard technique in the field and have been validated historically for studying the function of proteins, particularly those involved in metabolic pathways."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_steps": [
            {
              "sub_step_number": "3a",
              "questions": [
                {
                  "question": "Were basic controls included for this assay? Specifically, were 'Normal/Negative/Wild type' AND 'Abnormal/Positive/Null' controls used?",
                  "answer": "Yes"
                },
                {
                  "question": "Did the paper explicitly state that multiple replicates were used for the experiments?",
                  "answer": "Not mentioned"
                }
              ],
              "judgment": "Proceed to Sub-step 3b."
            },
            {
              "sub_step_number": "3b",
              "questions": [
                {
                  "question": "Has the specific instance of the assay been broadly accepted historically (e.g., standard technique in the field)? OR Previously validated in other studies (cited)? OR Provided as a commercial kit with defined performance metrics, but where controls/replicates are not documented for the specific instance of the assay in this paper?",
                  "answer": "Enzyme activity assays have been broadly accepted historically and validated in many studies."
                }
              ],
              "judgment": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
            }
          ]
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_steps": [
            {
              "sub_step_number": "4a",
              "questions": [
                {
                  "question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?",
                  "answer": "Not mentioned"
                }
              ],
              "judgment": "Proceed to Sub-step 4b."
            },
            {
              "sub_step_number": "4b",
              "questions": [
                {
                  "question": "How many total benign/pathogenic variant controls were used across the entire study (as applicable to this variant's assay)?",
                  "answer": "Not mentioned"
                }
              ],
              "judgment": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
            }
          ]
        }
      ]
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "A",
          "alt": "C",
          "position": "27"
        },
        "variant_string_id": "PINK1 A27C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The study aimed to analyze fibroblasts from a patient carrying the homozygous mutation p.W437X in the PTEN-induced kinase 1 (PINK1), which manifested a very early onset parkinsonism.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines that the patient has a homozygous mutation in PINK1 gene, which is associated with an early onset Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper uses enzyme activity assay to analyze the effect of the variant on the protein function.",
          "judgment": "Yes",
          "reasoning": "Enzyme activity assays are a standard technique in the field and have been validated historically for studying the function of proteins, particularly those involved in metabolic pathways."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_steps": [
            {
              "sub_step_number": "3a",
              "questions": [
                {
                  "question": "Were basic controls included for this assay? Specifically, were 'Normal/Negative/Wild type' AND 'Abnormal/Positive/Null' controls used?",
                  "answer": "Yes"
                },
                {
                  "question": "Did the paper explicitly state that multiple replicates were used for the experiments?",
                  "answer": "Not mentioned"
                }
              ],
              "judgment": "Proceed to Sub-step 3b."
            },
            {
              "sub_step_number": "3b",
              "questions": [
                {
                  "question": "Has the specific instance of the assay been broadly accepted historically (e.g., standard technique in the field)? OR Previously validated in other studies (cited)? OR Provided as a commercial kit with defined performance metrics, but where controls/replicates are not documented for the specific instance of the assay in this paper?",
                  "answer": "Enzyme activity assays have been broadly accepted historically and validated in many studies."
                }
              ],
              "judgment": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
            }
          ]
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_steps": [
            {
              "sub_step_number": "4a",
              "questions": [
                {
                  "question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?",
                  "answer": "Not mentioned"
                }
              ],
              "judgment": "Proceed to Sub-step 4b."
            },
            {
              "sub_step_number": "4b",
              "questions": [
                {
                  "question": "How many total benign/pathogenic variant controls were used across the entire study (as applicable to this variant's assay)?",
                  "answer": "Not mentioned"
                }
              ],
              "judgment": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
            }
          ]
        }
      ]
    }
  ]
}